Loss of energy homeostasis contributes to hepatic damage development in sickle cell disease
Lucía Beltrán-Camacho, Mercedes Vallejo-Mudarra, Isabel Pozuelo-Sánchez, Cristina García-Caballero, Marta Rojas-Torres, Iolanda Lazaro, Aleix Sala-Vila, Leo Valentín-Aragón, Javier Caballero-Villarraso, Lucas Opazo-Rios, Fernando Leiva-Cepas, Sebastián Mas-Fontao, Jesús Egido

TL;DR
This study explores how energy imbalance in the liver contributes to liver damage in sickle cell disease.
Contribution
The study reveals a previously unknown link between energy homeostasis disruption and liver damage in sickle cell disease.
Findings
SCD mice show iron overload and liver ischemia, leading to inflammation and tissue damage.
Energetic impairment in SCD livers is linked to mitochondrial dysfunction and oxidative stress.
Lipid metabolism changes and foam cell accumulation are observed in SCD mouse livers.
Abstract
Sickle cell disease (SCD) is characterized by the expression of an abnormal hemoglobin variant (HbS) that promotes distortion and early destruction of red blood cells, resulting in hemolytic anemia, vaso-occlusive crisis, ischemia and, ultimately, tissue damage. Hepatic function is specially compromised in SCD patients; however, the underlying pathological mechanisms remain largely unknown. In the current study, we confirmed the presence of hepatic damage in a murine model of SCD and, through a label free quantitative proteomic approach, we identified significant alterations in protein expression compared to healthy controls. These changes unveiled distinct proteome expression profiles between groups, with molecular alterations linked to impaired hepatic function, anemia, mitochondrial dysfunction, and alteration in lipid metabolism. We also confirmed these novel alterations through…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHemoglobinopathies and Related Disorders · Iron Metabolism and Disorders · Myeloproliferative Neoplasms: Diagnosis and Treatment
